["A Facebook post, shared more than 200 times and archived here,\u00a0features a TikTok clip taken from an interview of Bourla on the US news network\u00a0CNBC.", "\u201cThe chairman/CEO of Pfizer, the company that produces the COVID419 vaccine, Albert Bourla, says he will not take the vaccine,\u201d reads the caption on the post. \u201c... in fact in his words he said and I quote: \u2018...MY TYPE IS NOT RECOMMENDED TO TAKE THE VACCINE\u2026\u2019 (sic)\u201d.", "The post\u00a0from a Nigerian page\u00a0expresses strong anti-vaccine sentiments, claiming vaccine distribution is a plan by \u201cthe devil\u201d to deceive Christians.", "The video clip shared with the post\u00a0shows Bourla discussing his company\u2019s vaccine for Covid-19 in an interview on CNBC. In the clip, he urges those who are undecided about getting the shot to\u00a0trust the science behind it.", "Contrary to the post\u2019s claim, Bourla commits to getting the jab, but adds that he will follow the government's recommended schedule for people in his age group and with his health profile.", "\u201cAs soon as I can, I will,\u201d Bourla said. \u201cThe only sensitivity here is that I don't want to have an example that I am cutting the line. I\u2019m 59 years old, in good health;\u00a0I am not working in the frontline. My type is not recommended to get the vaccination now.\u201d The final word \u201cnow\u201d is omitted in the Facebook post's text.", "The complete version of the interview, posted on CNBC's\u00a0YouTube channel on December 14, 2020,\u00a0gives accurate context to Bourla\u2019s comments.", "He explained that according to a poll conducted by Pfizer, more people would accept the vaccine if they saw the company\u2019s CEO and staff take the jab. Bourla noted that he and his employees would receive the vaccine according to the recommended timeline.", "In another interview with CNN\u00a0in mid-December, Bourla repeated that he had not yet taken the vaccine, again stating that he was following vaccination recommendations\u00a0recommendations from the US Centers for Disease Control and Prevention (CDC) giving first preference to selected groups, none of which included him.", "According to the CDC, the initial supply of Covid-19 vaccines should be allocated to healthcare workers and long-term care facility residents, followed by frontline essential workers (for example firefighters and police officers) and people 75 and older.", "Those aged 65 to 74 would be next in line, along with people 16-64 who have underlying medical conditions, and other essential workers.", "On January 25, 2021, Bourla tweeted a picture of his father-in-law who had been vaccinated. \u201cAt 84, he is high-risk & graciously waited his turn in Greece,\u201d read Bourla\u2019s tweet.", "This is my father-in-law, the 1st member of our family to receive his 1st dose of the vaccine. At 84, he is high-risk & graciously waited his turn in Greece. I've heard many stories from people filled w/ emotion at seeing their loved ones get vaccinated. Now, I know the feeling. pic.twitter.com/oTSdtB3HZp", "More than 86 million doses\u00a0have been administered globally as of January 29, 2021, according to an AFP tally. More than 26 million of those are in the US.", "Follow us", "Copyright \u00a9 AFP 2017-2023. All rights reserved. Users can access and consult this website and use the share features available for personal, private, and non-commercial purposes.  Any other use, in particular any reproduction, communication to the public or distribution of the content of this website, in whole or in part, for any other purpose and/or by any other means, without a specific licence agreement signed with AFP, is strictly prohibited.  The subject matter depicted or included via links within the Fact Checking content is provided to the extent necessary for correct understanding of the verification of the information concerned.  AFP has not obtained any rights from the authors or copyright owners of this third party content and shall incur no liability in this regard.  AFP and its logo are registered trademarks."]